(Br8) Peripheral Thrombectomy
Payments companies reported to CMS as associated with (Br8) Peripheral Thrombectomy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (Br8) Peripheral Thrombectomy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (Br8) Peripheral Thrombectomy
These are the largest totals companies reported as associated with (Br8) Peripheral Thrombectomy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Miltiadis Leon | San Angelo, TX | Interventional Cardiology | $147.14 |
| Andrew Nimmich | Napa, CA | Vascular Surgery | $85.64 |
| Danielle Salazar | Washington, DC | Vascular Surgery | $82.83 |
| Rajesh Dave | Camp Hill, PA | Cardiovascular Disease | $65.93 |
| Mohammad Raja | El Paso, TX | Interventional Cardiology | $26.02 |
| Theodore Pabst | Plattsburgh, NY | Vascular Surgery | $25.75 |
| Christopher Skillern | Ventura, CA | Vascular Surgery | $23.53 |
| Omar Mubarak | Denver, CO | $22.65 | |
| Barbara Melendez | Denver, CO | Vascular Surgery | $22.65 |
| Chelsea Ledbetter | Pensacola, FL | Acute Care (Nurse Practitioner) | $21.17 |
Prescribed (Br8) Peripheral Thrombectomy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.